FocusPerformancePartnership
In Portfolio

Nemera

Nemera is a world leader in the design, development, and manufacture of drug delivery devices for the pharmaceutical, biotech, and generics industries.

Nemera
Overview

Nemera manufactures delivery devices in five main delivery route segments, of which parenteral (insulin pens, auto-injectors, and safety devices), inhalation (dry powder inhalers and pressurized metered inhalers), nasal/buccal/auricular (spray pumps, actuators, and valves), dermal (advanced airless pump-based dispensing systems) and ophthalmic (preservative-free multi-dose eye droppers). The company addresses the needs of blue-chip customers through two different business models: contract manufacturing and proprietary devices.

Head office

Headquartered in La Verpillière (France), the company employs ca. 2,700 people across four manufacturing facilities in France, Germany, and the United States and one innovation centre across France and the United States.

Global sales

c.€800M sales.

Nemera’s products are sold to a variety of blue-chip customers from the pharmaceutical, biotech and generics industries.



Healthcare sector2019 Entry into PortfolioFund Astorg VI3,200 EMPLOYEESHealthcare sector2019 Entry into PortfolioFund Astorg VI3,200 EMPLOYEESHealthcare sector2019 Entry into PortfolioFund Astorg VI3,200 EMPLOYEESHealthcare sector2019 Entry into PortfolioFund Astorg VI3,200 EMPLOYEES

Meet the team behind our deep
expertise and market-leading results

Thierry Timsit

Executive Chairman

Thierry Timsit
Nicolas Marien

Partner, Head of France and Benelux Flagship

Nicolas Marien
Antoine Thomas

Director

Antoine Thomas
Fayçal Battou

Associate

Fayçal Battou

Recent News

Montagu and Astorg welcome LGT Capital Partners as minority shareholder in Nemera
ViewMore
Healthcare
news
Montagu and Astorg welcome LGT Capital Partners as minority shareholder in Nemera
Aug 13, 2025
Nemera breaks ground in Brazil through Milfra acquisition
ViewMore
Healthcare
news
Nemera breaks ground in Brazil through Milfra acquisition
Jun 18, 2021
Montagu and Astorg enter into an exclusive agreement to form a partnership on Nemera
ViewMore
Healthcare
news
Montagu and Astorg enter into an exclusive agreement to form a partnership on Nemera
Oct 17, 2018
Laboratoire Cerba
ViewMore
Laboratoire Cerba
Sebia
ViewMore
Sebia
Oxoid Remel Microbiology
ViewMore
Oxoid Remel Microbiology
Sebia
ViewMore
Sebia
Sebia
ViewMore
Sebia
Sebia
ViewMore
Sebia
Laboratoire Cerba
ViewMore
Laboratoire Cerba
Sebia
ViewMore
Sebia
Oxoid Remel Microbiology
ViewMore
Oxoid Remel Microbiology
Sebia
ViewMore
Sebia
Sebia
ViewMore
Sebia
Sebia
ViewMore
Sebia